The mammoth drug maker GlaxoSmithKline agreed to pay a record $3 billion fraud settlement with the Justice Department in a deal announced Monday about the way the company marketed and sold some of its most popular drugs.
This is a companion discussion topic for the original entry at https://talkingpointsmemo.com/?p=97436